Self-expanding transcatheter aortic valve infolding: Current evidence, diagnosis, and management
- PMID: 33315300
- DOI: 10.1002/ccd.29432
Self-expanding transcatheter aortic valve infolding: Current evidence, diagnosis, and management
Abstract
Background: Prosthetic valve infolding is a rare but severe complication of transcatheter aortic valve implantation (TAVI) with self-expanding valves. However, currently available clinical data are limited and fragmented.
Objectives: This report aims to provide a comprehensive overview of this complication focusing on predisposing factors, clinical presentation, diagnostic findings, treatment and clinical outcomes.
Methods: A systematic review of the literature was performed to identify cases of infolding occurring during TAVI with self-expanding valves published until August 2020. These data were pooled with all the retrospectively identified infolding cases occurred at San Raffaele Scientific Institute between December 2014 and August 2020.
Results: A total of 34 cases were included. Among patients with available data, 38% received a first-generation CoreValve, and 62% a second-generation Evolut R (82%) or Evolut PRO (18%). Infolding occurred mostly with ≥29-mm valves (94%). Predisposing factors included resheathing of a second-generation valve (82%), heavy calcification of the native valve (65%), lack of predilatation (16%), Sievers type-1 bicuspid aortic valve (11%), and improper valve loading (5%). Infolding resulted in severe PVL causing hemodynamic instability (29%) or cardiac arrest (12%). Postdilatation was the treatment strategy in 68%, while prosthesis replacement with a new device in 23% of cases. Device success rate was 82%. Death and stroke occurred in 3% and 12% of cases.
Conclusions: Prosthetic valve infolding is typically observed after resheathing of a large-size self-expanding TAVI. When infolding is timely diagnosed, prosthesis removal and replacement should be pursued. Further studies are required to precisely define predisposing factors to prevent this complication.
Keywords: self-expanding transcatheter heart valve; transcatheter aortic valve implantation.
© 2020 Wiley Periodicals LLC.
References
REFERENCES
-
- Sinning JM, Vasa-Nicotera M, Ghanem A, Grube E, Nickenig G, Werner N. An exceptional case of frame underexpansion with a self-expandable transcatheter heart valve despite predilation. JACC Cardiovasc Interv. 2012;5(12):1288-1289. https://doi.org/10.1016/j.jcin.2012.07.014.
-
- Pozzi M, Rioufol G, Delannoy B, et al. The “pAC-MAN” sign: an insidious complication after transcatheter aortic valve deployment. Int J Cardiol. 2013;167(6):e192-e194. https://doi.org/10.1016/j.ijcard.2013.04.021.
-
- Souteyrand G, Wilczek K, Innorta A, et al. Distortion of the CoreValve during transcatheter aortic valve-in-valve implantation due to valve dislocation. Cardiovasc Revascularization Med. 2013;14(5):294-298. https://doi.org/10.1016/j.carrev.2013.05.004.
-
- Wiper A, Chauhan A, More R, Roberts D. CoreValve frame distortion: the importance of meticulous valve loading. JACC Cardiovasc Interv. 2014;7(2):222-223. https://doi.org/10.1016/j.jcin.2013.05.032.
-
- Kamperidis V, Van Der Kley F, Katsanos S, Delgado V. CoreValve stent frame misdeployment and increased transvalvular gradient. Eur Heart J Cardiovasc Imaging. 2014;15(7):832. https://doi.org/10.1093/ehjci/jeu005.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources